Akerley, Wallace L <br/><br/>
Impact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small-cell lung cancer.  [electronic resource] 

 -  Current medical research and opinion  06 2017 
 - 1091-1097 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1080/03007995.2017.1301903  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mutation<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proteomics